Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for ...

"People that have asthma, people that have chronic lung disorders, they tend to get exacerbations or triggering their lung ...

The study of success eating food triggers after stopping Xolair is ongoing, so researchers are still collecting data for doctors to use making treatment plans with their patients. Parents interested ...

Following use of race-neutral lung function equations, African American and Latino pediatric patients with asthma had reductions in FEV1 and FVC while white patients with asthma had increases, ...

The first stoves have been installed in Martinez, California and the manufacturer says it will deliver 10,000 units to the New York City Housing Authority in 2026.

Despite ongoing progress, structural racism and health disparities continue to shape healthcare practices in ways healthcare providers may not even realize.

We know that we are not adequately testing for bird flu in the Central Valley. This means we may have more cases unaccounted ...

Researchers found increased odds for clinical remission on dupilumab with high blood eosinophil and fractional exhaled nitric ...

Treatment with tezepelumab has been effective for sinonasal symptoms in patients with severe, uncontrolled asthma and a ...

Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and ...

VATICAN CITY – Pope Francis, who has been hospitalized for just over two weeks fighting double pneumonia, is in a stable condition and has not had further breathing crises, the Vatican said on ...

Seasonal allergies affect roughly 100 million people in the U.S., according to the American College of Allergy, Asthma & Immunology.